Today's announcement really shows that Mesoblast is working smartly to address the FDA's legitimate concerns about how Mesoblast would be able to deliver consistent product on a mass production scale. Partnering with Novaris ticks that box and brings us so much closer to the fda giving their approval. Well done SI for working with the system! He's a pro.
Ann: First Quarter Financial Results on Form 6-K, page-10
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.5¢ |
Change
0.035(3.72%) |
Mkt cap ! $1.110B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 98.0¢ | 92.0¢ | $2.597M | 2.710M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 11102 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.0¢ | 149358 | 21 |
View Market Depth
| Last trade - 14.19pm 03/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |